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Background: Streptococcus pneumoniae infections are challeng-
ing sincepneumococcihavemore than90serotypesandemergence
of resistant strains has increased. Surveillance systems are essen-
tial for effective vaccine strategies and development of treatment
protocols. This study aimed to evaluate the serotype distribution
and antimicrobial susceptibility of S. pneumoniae causing invasive
pneumococcal disease in adults (>18 years).
Methods & Materials: S. pneumoniae strains were collected
from 14 different centers between 2005 and 2015. Pneumococcal
serogroup and serotype identiﬁcation was performed using stan-
dard conventional methods. Antibiotic susceptibility testing was
performed using E-test and interpreted according to the CLSI 2014
standards.
Results: S. pneumonia strains (n =346) were isolated from
blood (60.1%), bronchoalveolar lavage (19.7%), cerebrospinal ﬂuid
(11.0%), pleural ﬂuid (6.1%), and other body ﬂuids (3.1%). The most
common S. pneumoniae serotypeswere found as serotype 3 (13.0%),
19F (12.7%), 19A (6.1%), 14 (4.6%), and 6B (4.0%). Vaccine cover-
age rate was 27.4% for 7-valent pneumococcal conjugate vaccine
(PCV-7), 53.5% for PCV-13, and 62.3% for 23-valent pneumococcal
polysaccharide vaccine (PPV-23). For oral penicillin V, resistance
ratewas 21.7% and intermediate resistance ratewas 16.8%. For par-
enteral penicillin, 52.6% was resistant in strains isolated from CSF
(meningitis) and 0.6% was resistant and 5.8% was intermediate in
Table 1
Penicillin
V (oral)
Penicillin
parenteral
(non-meningitis)
Penicillin
parenteral
(meningitis)
Erythromycin
Coverage rates for
PCV-7 52.0% 60.0% 40.0% 55.6%
PCV-13 68.6% 90.0% 65.0% 76.7%
PPV-23 74.7% 85.0% 75.0% 79.7%
strains isolated from other specimens. For cefotaxime, 5.3% was
resistant and 18.4% was intermediate in strains isolated from CSF,
whereas 1.6% was resistant and 6.5% was intermediate in strains
isolated fromother specimens. Erythromycin resistancewas 28.6%.
No resistancewas detected tomoxiﬂoxacin but intermediate resis-
tance was 0.6%. Serotypes 19A and 19F exhibited higher rates of
penicillin and erythromycin resistances. Vaccine coverage rates for
non-susceptible (resistant and intermediate) strains are presented
in Table 1.
Conclusion: Since serotype distribution and antimicrobial sus-
ceptibility of clinical S. pneumoniae isolates may change in time
naturally also with medical interventions like antibiotic use and
vaccination, close monitoring is essential.
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Background: Brucellosis is a widespread zoonotic disease with
signiﬁcant economic and major public health problem. Failure of
response and relapse of brucellosis have reported with current
therapeutic regimens. Considering the high prevalence of brucel-
losis and recurrence rate of this disease in Iran, widespread and
inappropriate use of antibiotics could redound antibiotic resistance
among Brucella isolates in the community. The aim of this study
was to evaluate the antibiotic susceptibility pattern of Brucella iso-
lates by E-test method in Hamadan, west of Iran.
Methods & Materials: In this study, patients with clinical diag-
nosis of brucellosis who referred to Infectious Diseases Ward,
Sina hospital in Hamadan were studied between April 2013
and July 2014. Blood Specimens were collected for diagnosis of
brucellosis by BACTEC blood culture system. Antimicrobial sus-
ceptibility patterns of clinical isolates to gentamicin, streptomycin,
rifampin, doxycycline, ciproﬂoxacin, oﬂoxacin and trimethoprim-
sulfamethoxazole were performed by the E-test method. Then the
